Increasing the dose of varenicline in patients who do not respond to the standard dose

Mayo Clinic Proceedings

Volumn 88, Issue 12, 2013, Pages 1443-1445

  Jiménez Ruiz, Carlos A ^a   Barrios, Malena ^b   Peña, Sandra ^b   Cicero, Ana ^a   Mayayo, Marisa ^a   Cristóbal, Maribel ^a   Perera, Lidia ^a  

^a Smoking Cessation Service   (Spain)

^b British Hospital Montevideo   (Uruguay)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; VARENICLINE; BENZAZEPINE DERIVATIVE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA4BETA2; QUINOXALINE DERIVATIVE;

ABNORMAL DREAMING; ADULT; BEHAVIOR THERAPY; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; REVIEW; SMOKING CESSATION; TREATMENT RESPONSE; VOMITING; WITHDRAWAL SYNDROME; AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG EFFECT; MEDICAL RECORD; METHODOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY; SMOKING; TREATMENT OUTCOME; CHEMICALLY INDUCED; DRUG EFFECTS; DRUG THERAPY; PROCEDURES;

ADULT; AGED; BENZAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; NAUSEA; NICOTINIC AGONISTS; QUINOXALINES; RECEPTORS, NICOTINIC; RETROSPECTIVE STUDIES; SLEEP INITIATION AND MAINTENANCE DISORDERS; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME; VOMITING;

EID: 84892959628     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mayocp.2013.08.015     Document Type: Article

References (4)

1. Reus VI, Obach RS, Coe JW, et al. Varenicline: new treatment with efficacy in smoking cessation. Drugs Today (Barc). 2007; 43(2):65-75.
2. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2012;4: CD006103.
3. 2008 PHS Guideline Update Panel, Liaisons, and Staff. Treating tobacco use and dependence: 2008 update U.S. Public Health Service Clinical Practice Guideline executive summary. Respir Care. 2008;53(9):1217-1222.
4. Hajek P, McRobbie HJ, Myers KE, Stapleton J, Dhanji AR. Use of varenicline for 4 weeks before quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates. Arch Intern Med. 2011;171(8):770-777.